Author:
Bandaru Nagaraju,Rao A. Narayana,Deepika Yasho,Ketha Alekhya,Thathipudi Daveedu,Sri Laxmi N.
Abstract
The Fraction from Methanolic extract whole plant of Biophytum reinwardtii (HEMBR) is traditionally used in the treatment of diabetes. Rats were treated with a standardized dose of Dexamethasone for 14 days and the effect of HEMBR at the doses of 50 and 100 mg/kg, p.o. on plasma blood glucose level, serum triglyceride level, glucose uptake in skeletal muscle, levels of hepatic antioxidant enzymes (GSH, SOD and catalase), and body weight were observed. HEMBR showed a significant decrease in plasma glucose and serum triglyceride levels (p < 0.01) at the dose of 50 and 100 mg/kg, p.o. and also stimulated glucose uptake in skeletal muscle. The levels of antioxidant enzymes, GSH, SOD, and catalase were significantly increased (p < 0.01). Hence it can be concluded that Biophytum reinwardtii may prove to be effective in the treatment of Type-II Diabetes mellitus owing to its ability to decrease insulin resistance.
Publisher
Informatics Publishing Limited
Subject
Health, Toxicology and Mutagenesis,Toxicology,Health, Toxicology and Mutagenesis,Toxicology
Reference20 articles.
1. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration. 2010; 375:2215- 22. https://doi.org/10.1016/S0140-6736(10)60484-9 PMid:20609967
2. Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, et al. Causes of vision loss worldwide, 1990-2010: A systematic analysis. Lancet Global Health 2013; 1:e339-49. https://doi.org/10.1016/S2214- 109X(13)70113-X PMid:25104599
3. 2014 USRDS Annual Data Report. Epidemiology of kid¬ney disease in the United States. United States Renal Data System. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2014. p. 188-210.
4. Fowler MJ. Diabetes treatment, Part 2: Oral agents for glycemic management. Clin Diabetes. 2007; 25:131-4 https://doi.org/10.2337/diaclin.25.4.131
5. Geer EB, Islam J, Buettner C. Mechanisms of glucocorti¬coid-induced insulin resistance: Focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am. 2014; 43:75-102. https://doi.org/10.1016/j. ecl.2013.10.005 PMid:24582093 PMCid:PMC3942672